AVEO Oncology
AVEO
#7099
Rank
โ‚ฌ0.44 B
Marketcap
12,88ย โ‚ฌ
Share price
0.00%
Change (1 day)
146.17%
Change (1 year)

Revenue for AVEO Oncology (AVEO)

Revenue in 2022 (TTM): โ‚ฌ89.74 Million

According to AVEO Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ81.01 Million. In 2021 the company made a revenue of โ‚ฌ37.34 Million an increase over the revenue in the year 2020 that were of โ‚ฌ4.89 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AVEO Oncology from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ89.74 M140.31%
2021 โ‚ฌ37.34 M663.18%
2020 โ‚ฌ4.89 M-80.96%
2019 โ‚ฌ25.7 M443.65%
2018 โ‚ฌ4.72 M-25.15%
2017 โ‚ฌ6.31 M164.18%
2016 โ‚ฌ2.39 M-86.26%
2015 โ‚ฌ17.39 M16.76%
2014 โ‚ฌ14.9 M1491.64%
2013 โ‚ฌ0.93 M-93.58%
2012 โ‚ฌ14.58 M-88.51%
2011 โ‚ฌ0.12 B277.88%
2010 โ‚ฌ33.59 M132.29%
2009 โ‚ฌ14.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
โ‚ฌ8.64 B 10,572.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ12.23 B 15,005.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B 50,827.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.03 B 62,898.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.89 B 38,037.60%๐Ÿ‡บ๐Ÿ‡ธ USA